| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |